v3.26.1
CONSOLIDATED STATEMENTS OF CHANGES IN SHAREHOLDERS’ EQUITY - USD ($)
shares in Thousands, $ in Thousands
Total
Common Stock
Additional paid-in capital
Accumulated deficit
Accumulated other Comprehensive loss
Statutory reserves
Beginning balance (in shares) at Dec. 31, 2024   323,144        
Beginning balance at Dec. 31, 2024 $ 387,895 $ 33 $ 1,512,982 $ (1,092,958) $ (38,194) $ 6,032
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net profit 61,790     61,790    
Issuance of common stock in connection with vesting of share-based awards (in shares)   385        
Share-based compensation 703   703      
Foreign currency translation adjustments 3,847       3,847  
Ending balance (in shares) at Mar. 31, 2025   323,529        
Ending balance at Mar. 31, 2025 $ 454,235 $ 33 1,513,685 (1,031,168) (34,347) 6,032
Beginning balance (in shares) at Dec. 31, 2025 331,786 331,786        
Beginning balance at Dec. 31, 2025 $ 410,513 $ 34 1,543,797 (1,122,176) (17,174) 6,032
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net profit 48,211     48,211    
Issuance of common stock in connection with vesting of share-based awards (in shares)   1,371        
Share-based compensation 1,008   1,008      
Foreign currency translation adjustments $ 6,374       6,374  
Ending balance (in shares) at Mar. 31, 2026 333,157 333,157        
Ending balance at Mar. 31, 2026 $ 466,106 $ 34 $ 1,544,805 $ (1,073,965) $ (10,800) $ 6,032